BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31175628)

  • 1. The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made?
    Lim J; Allen PJ
    Updates Surg; 2019 Jun; 71(2):209-216. PubMed ID: 31175628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytologic Evaluation of Intraductal Papillary Mucinous Neoplasm and Mucinous Cystic Neoplasms of Pancreas.
    Gilani SM; Adeniran AJ; Cai G
    Am J Clin Pathol; 2020 Sep; 154(4):559-570. PubMed ID: 32589187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Develop Nomogram to Predict Malignancy of Intraductal Papillary Mucinous Neoplasm.
    Kim Y; Park T
    Methods Mol Biol; 2019; 1882():23-32. PubMed ID: 30378041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas.
    Cortegoso Valdivia P; Chialà C; Venezia L; Gaiani F; Leandro G; Di Mario F; De' Angelis GL
    Acta Biomed; 2018 Dec; 89(9-S):147-152. PubMed ID: 30561408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).
    Sereni E; Luchini C; Salvia R; Pea A
    Chin Clin Oncol; 2019 Apr; 8(2):21. PubMed ID: 31070041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
    Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
    J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intraductal papillary mucinous neoplasm of pancreas].
    Panteleev VI; Gorin DS; Kaldarov AR; Kriger AG
    Khirurgiia (Mosk); 2019; (11):81-87. PubMed ID: 31714535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of host- and tumor-derived markers for predicting high-grade dysplasia and associated invasive carcinoma of intraductal papillary mucinous neoplasms of the pancreas.
    Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Naitoh T; Furukawa T; Unno M
    Surg Today; 2020 Sep; 50(9):1039-1048. PubMed ID: 32124086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
    Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of intraductal papillary mucinous neoplasms of the pancreas.
    Pollini T; Andrianello S; Caravati A; Perri G; Malleo G; Paiella S; Marchegiani G; Salvia R
    Minerva Chir; 2019 Oct; 74(5):414-421. PubMed ID: 31795628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
    Srinivasan N; Koh YX; Goh BKP
    Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral Predictors of Malignancy in IPMN: A Review of the Literature.
    Nista EC; Schepis T; Candelli M; Giuli L; Pignataro G; Franceschi F; Gasbarrini A; Ojetti V
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?
    Sharib JM; Fonseca AL; Swords DS; Jaradeh K; Bracci PM; Firpo MA; Hatcher S; Scaife CL; Wang H; Kim GE; Mulvihill SJ; Maitra A; Koay EJ; Kirkwood KS
    Surgery; 2018 Dec; 164(6):1178-1184. PubMed ID: 30170819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
    Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Management and Surgical Decision-Making of IPMN of the Pancreas.
    Tanaka M
    Methods Mol Biol; 2019; 1882():9-22. PubMed ID: 30378040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
    Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
    Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.